**Core Concept:** Hydralazine is a vasodilator medication used in the treatment of hypertension, congestive heart failure, and Raynaud's phenomenon. It works by inhibiting the enzyme phosphodiesterase and increasing cyclic GMP levels, leading to smooth muscle relaxation and vasodilation.

**Why the Correct Answer is Right:**
Option A is incorrect because hydralazine does have vasodilatory effects and is used in the management of hypertension and congestive heart failure.

Option B is incorrect because hydralazine does not specifically target the renin-angiotensin-aldosterone system (RAAS). It is a phosphodiesterase inhibitor, as mentioned before.

Option C is incorrect because hydralazine is not primarily used for Raynaud's phenomenon treatment. It is mainly used for hypertension and heart failure.

Option D is incorrect because hydralazine is not a beta-blocker. It belongs to the class of phosphodiesterase inhibitors and has vasodilatory effects.

**Why Each Wrong Option is Wrong:**
Option A is incorrect because hydralazine is not a calcium channel blocker. It works through phosphodiesterase inhibition, which leads to vasodilation and reduction of blood pressure.

Option B is incorrect because hydralazine does not specifically target the renin-angiotensin-aldosterone system (RAAS). The RAAS inhibitors, like angiotensin-converting enzyme inhibitors (ACE inhibitors) and angiotensin II receptor blockers (ARBs), are more appropriate for RAAS targeting.

Option C is incorrect because hydralazine is not a calcium channel blocker. As mentioned, hydralazine works primarily through phosphodiesterase inhibition.

Option D is incorrect because hydralazine is not a beta-blocker. It works through vasodilation and reduction of blood pressure, which are different mechanisms from beta-blockers.

**Clinical Pearl:**
Hydralazine is a versatile drug that can be used in the treatment of hypertension, heart failure, and Raynaud's phenomenon. However, it should be used with caution in patients with low blood pressure (hypotension), as it can exacerbate the condition by further reducing blood pressure. This highlights the importance of considering individual patient characteristics and comorbidities while prescribing medications.